Crescita Therapeutics (CTX) Competitors C$0.64 +0.02 (+3.23%) (As of 11/22/2024 05:18 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlines CTX vs. VIR, ZOM, IN, META, LABS, CWEB, DB, NRTH, MRV, and WLLWShould you be buying Crescita Therapeutics stock or one of its competitors? The main competitors of Crescita Therapeutics include Viridium Pacific Group (VIR), Zomedica Pharmaceuticals Corp. (ZOM.V) (ZOM), InMed Pharmaceuticals (IN), Meta Growth (META), MediPharm Labs (LABS), Charlotte's Web (CWEB), Decibel Cannabis (DB), 48North Cannabis (NRTH), Nuvo Pharmaceuticals (MRV), and Willow Biosciences (WLLW). These companies are all part of the "drug manufacturers - specialty & generic" industry. Crescita Therapeutics vs. Viridium Pacific Group Zomedica Pharmaceuticals Corp. (ZOM.V) InMed Pharmaceuticals Meta Growth MediPharm Labs Charlotte's Web Decibel Cannabis 48North Cannabis Nuvo Pharmaceuticals Willow Biosciences Viridium Pacific Group (CVE:VIR) and Crescita Therapeutics (TSE:CTX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, community ranking, analyst recommendations, dividends, media sentiment, institutional ownership and profitability. Is VIR or CTX more profitable? Viridium Pacific Group has a net margin of 0.00% compared to Crescita Therapeutics' net margin of -17.72%. Viridium Pacific Group's return on equity of 0.00% beat Crescita Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Viridium Pacific GroupN/A N/A N/A Crescita Therapeutics -17.72%-15.79%-8.26% Does the media favor VIR or CTX? In the previous week, Crescita Therapeutics had 1 more articles in the media than Viridium Pacific Group. MarketBeat recorded 1 mentions for Crescita Therapeutics and 0 mentions for Viridium Pacific Group. Viridium Pacific Group's average media sentiment score of 0.00 beat Crescita Therapeutics' score of -1.32 indicating that Viridium Pacific Group is being referred to more favorably in the media. Company Overall Sentiment Viridium Pacific Group Neutral Crescita Therapeutics Negative Which has better earnings & valuation, VIR or CTX? Crescita Therapeutics has higher revenue and earnings than Viridium Pacific Group. Crescita Therapeutics is trading at a lower price-to-earnings ratio than Viridium Pacific Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioViridium Pacific GroupC$1.09M34.46-C$12.64M-C$0.13-2.97Crescita TherapeuticsC$16.84M0.74-C$2.98M-C$0.15-4.27 Does the MarketBeat Community favor VIR or CTX? Crescita Therapeutics received 20 more outperform votes than Viridium Pacific Group when rated by MarketBeat users. However, 83.33% of users gave Viridium Pacific Group an outperform vote while only 67.42% of users gave Crescita Therapeutics an outperform vote. CompanyUnderperformOutperformViridium Pacific GroupOutperform Votes4083.33% Underperform Votes816.67%Crescita TherapeuticsOutperform Votes6067.42% Underperform Votes2932.58% SummaryViridium Pacific Group beats Crescita Therapeutics on 8 of the 12 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Crescita Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CTX vs. The Competition Export to ExcelMetricCrescita TherapeuticsDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$12.40MC$1.20BC$5.20BC$6.24BDividend YieldN/A3.13%5.53%5.42%P/E Ratio-4.27110.9079.4725.74Price / Sales0.741,759.861,246.761,452.58Price / Cash1.2010.3340.9084.36Price / Book0.723.067.192.75Net Income-C$2.98MC$155.49MC$119.54MC$289.45M7 Day PerformanceN/A-1.37%2.12%2.14%1 Month Performance4.92%-5.16%-2.43%0.64%1 Year Performance64.10%100.06%34.52%33.01% Crescita Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CTXCrescita TherapeuticsN/AC$0.64+3.2%N/A+64.1%C$12.40MC$16.84M-4.2762Negative NewsVIRViridium Pacific GroupN/AC$0.38+5.6%N/A+0.0%C$37.52MC$1.09M-2.97580Gap UpZOMZomedica Pharmaceuticals Corp. (ZOM.V)N/AC$0.29-6.6%N/A+0.0%C$36.73MN/A-2.6150Gap DownINInMed PharmaceuticalsN/AN/AN/AN/AC$33.73MC$574,677.00-2.7712METAMeta GrowthN/AC$0.14flatN/A+0.0%C$33.14MC$60.96M-0.6686,500Gap DownLABSMediPharm LabsN/AC$0.07flatN/A+0.0%C$28.78MC$37.76M-1.75130CWEBCharlotte's WebN/AC$0.18flatN/A-33.3%C$28.35MC$54.55M-0.45164High Trading VolumeDBDecibel Cannabis2.1168 of 5 starsC$0.07flatC$0.28+335.9%-55.2%C$26.59MC$105.60M-6.5083,000News CoverageNRTH48North CannabisN/AC$0.07-6.7%N/A+0.0%C$15.76MC$18.90M-0.3047MRVNuvo PharmaceuticalsN/AN/AN/AN/AC$15.38MC$72.42M-19.29N/AWLLWWillow BiosciencesN/AC$0.08flatN/A+14.3%C$11.54MC$1.84M-1.3319 Related Companies and Tools Related Companies VIR Alternatives ZOM Alternatives IN Alternatives META Alternatives LABS Alternatives CWEB Alternatives DB Alternatives NRTH Alternatives MRV Alternatives WLLW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:CTX) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crescita Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crescita Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.